Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
tranexamic acid
tranexamic acid
Brand names: Cyklokapron, Lysteda, TXA
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 100 mg/mL |
| TABLET, ORAL | 650 mg |
Last updated: Aug. 26, 2024
tranexamic acid
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 100 mg/mL |
| TABLET, ORAL | 650 mg |
Use in Knee and Hip Arthroplasty/Hemiarthroplasty (both IV and topical): See Guideline 900.5868
Tranexamic acid for thrombolytic reversal: See Reversal Guideline 900.5010
Anticoagluation Management while on ECMO, see protocol 922.5063
Massive Transfusion Protocol, see protocol 915.6150 and Pharmacologic Adjuncts for Massive Transfusion
P&T approved off-label route of administration for bladder irrigation (3 gm/3,030 mL)